The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Pain wakes me at 3:18 a.m., reminding me that lupus stopped me from working. “Yeah, I know,” I sleep-whisper and stare at the digital clock until box breathing cools me back to sleep. An hour later, 4 ...

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Kyverna Therapeutics plans to initiate a Phase 1 trial of KYV-101, a potential lupus nephritis treatment, in early 2023.

Sweet potatoes often appear at Thanksgiving and other holidays, but it’s time for them to be in the spotlight. Eating them can benefit your health.

The FDA has granted fast track status to ADI-001, Adicet Bio’s CAR T-cell therapy for treatment-resistant systemic lupus erythematosus (SLE).

The Medical Research Foundation has awarded its sixth Emerging Leaders Prize to three lupus researchers in the U.K.

Antibodies targeting the TFAM protein could increase the risk of blood clotting complications in people with lupus, a study found.

The U.S. Food and Drug Administration (FDA) has approved for commercial use new automated diagnostic tests for lupus and for ANCA-associated vasculitis, both of which use the HELIOS system.

The experimental therapy brepocitinib failed to show benefits beyond a placebo for systemic lupus erythematosus in a Phase 2 clinical trial.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded $3 million to a research team that’s using artificial intelligence (AI) to diagnose lupus nephritis, one of the ...